NCT02621008

Brief Summary

A self administered 16 weeks plus follow up study to explore the efficacy of mobile phone driven apps for stress reduction coupled with guidance for healthy living among obese and overweight populations. The Study primary end points are weight of the participants, as well as glucose measurements (for subject with diabetes) and blood pressure (of subjects with hypertension).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable diabetes

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

November 25, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 3, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

January 1, 2016

Status Verified

December 1, 2015

Enrollment Period

9 months

First QC Date

November 25, 2015

Last Update Submit

December 31, 2015

Conditions

Keywords

diabeteshypertensionobesitymobile phonestresshealthy livingpre-diabetes

Outcome Measures

Primary Outcomes (9)

  • BMI

    16 weeks

  • Glucose level

    16 weeks

  • blood pressure

    16 weeks

  • BMI

    6 months

  • BMI

    12 months

  • glucose level

    6 months

  • glucose level

    12 months

  • blood pressure

    6 months

  • blood pressure

    12 months

Secondary Outcomes (15)

  • Quality of Life questionnaire

    16 weeks

  • Quality of Life questionnaire

    6 months

  • Quality of Life questionnaire

    12 months

  • Burnout measure

    16 weeks

  • Burnout Measure

    6 months

  • +10 more secondary outcomes

Study Arms (1)

Stress Reduction& Healthy living

EXPERIMENTAL

Utilizing a stress reduction app (Serenita) and lifestyle intervention App (NewMe) and obtaining the NewMe guideline for healthy living, plus obtaining periodic messages regarding healthy living.

Other: Stress Reduction& Healthy living

Interventions

Utilizing a stress reduction app (Serenita) and lifestyle intervention App (NewMe) and obtaining the NewMe guideline for healthy living, plus obtaining periodic messages regarding healthy living.

Stress Reduction& Healthy living

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be 18 years of age or older and
  • have a body mass index (BMI) of at least 24 kg/m2 (22 kg/m2 if Asian) and
  • be able to engage in light physical activity

You may not qualify if:

  • no Internet access or use of iOS
  • taking more than three antihypertensive or diabetes drugs; meeting the DSM-5 criteria for an eating disorder
  • having a disability that prevents or hinders exercise and physical activity
  • receiving any treatment for weight loss elsewhere.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mt Sinai Medical Center

New York, New York, 10029, United States

RECRUITING

MeSH Terms

Conditions

Diabetes MellitusHypertensionGlucose IntoleranceOverweightObesityBody Weight

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular DiseasesCardiovascular DiseasesHyperglycemiaOvernutritionNutrition DisordersSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

oren fuerst, ph.d.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2015

First Posted

December 3, 2015

Study Start

November 1, 2015

Primary Completion

August 1, 2016

Study Completion

October 1, 2016

Last Updated

January 1, 2016

Record last verified: 2015-12

Locations